Hans Wilhelm Doerr

Medicine · Health Sciences

58h-index17.7kcitations361works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytomegalovirus and herpesvirus research(83), Herpesvirus Infections and Treatments(68), HIV Research and Treatment(59), HIV/AIDS drug development and treatment(40), Hepatitis C virus research(34)

Publications361 total

41514 Infektionskrankheiten
2025
Supplementary Figure 2 from Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
2023Open Access
Supplementary Figure 1 from Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
2023Open Access
Supplementary Figure 3 from Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
2023Open Access
Supplementary Figure 2 from Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
2023Open Access
Data from Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
2023Open Access
Supplementary Figure 1 from Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
2023Open Access
Supplementary Figure 3 from Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
2023Open Access
Supplementary Figure 4 from Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
2023Open Access
Supplementary Figure 4 from Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
2023Open Access
Supplementary Table 1 from Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
2023Open Access
Data from Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
2023Open Access
Supplementary Table 1 from Reversal of P-glycoprotein–Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
2023Open Access
S2k-Leitlinie zur Diagnostik und Therapie des Zoster und der Postzosterneuralgie
PubMed·2020· 6 citedOpen Access
S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia
JDDG Journal der Deutschen Dermatologischen Gesellschaft·2020· 124 citedOpen Access
S2k‐Leitlinie zur Diagnostik und Therapie des Zoster und der Postzosterneuralgie
JDDG Journal der Deutschen Dermatologischen Gesellschaft·2020· 35 citedOpen Access
Preventing vertical virus infections: the role of serologic screening of pregnant women
Medical Microbiology and Immunology·2018· 5 cited
14. Infektionskrankheiten
2018
Prevalence of K65R in patients treated with tenofovir disoproxil fumarate: recommendations based on the Frankfurt HIV Cohort Study Resistance Database (FHCS-RD)
Medical Microbiology and Immunology·2016· 3 cited
Vaccination against infectious diseases: What is promising?
Medical Microbiology and Immunology·2014· 16 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

Jindřich Činátl(25), Holger F. Rabenau(14), Martin Michaelis(12), Wolfgang Preiser(9), Annemarie Berger(8), Christian Drosten(4), Martin Stürmer(4), Florian Rothweiler(4), Jaroslav Činátl(4), Herbert Schmitz(3), Janina Geiler(3), Martin Scholz(3), Stephan Günther(2), Stephan Becker(2), Marcus Panning(2), Markus Eickmann(2), Hans‐Dieter Klenk(2), Albert D. M. E. Osterhaus(2), Jan ter Meulen(2), Edward N. van den Brink(2)